As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency ...

The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year.

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

Announced the acceptance of the New Drug Application (NDA) by the U.S. Food and Drug Administration (FDA) for OLC for the treatment of hyperphosphatemia in patients with CKD on dialysis. The FDA set a ...

Pluvicto, Novartis’ blockbuster radiopharmaceutical for prostate cancer, has been greenlighted by the FDA for use earlier in ...

Shares of U.S. drugmakers fell before the bell on Monday after reports that the Food and Drug Administration's top vaccine ...

The latest trading day saw Cloudflare (NET) settling at $112.69, representing a -1.94% change from its previous close.

For 13 years, Marks led the FDA's Center for Biologics Evaluation and Research, the department in charge of reviewing and approving vaccines, genetic medicines and cell therapies.Please watch the ...

Key players in the foreign exchange market are concerned about the potential of a "liquidity mirage," as they fear a proliferation of trading platforms and the widespread use of automation are ...